COVID-19-related prescribing challenge in intellectual disability.

Bushra RaufHafsa SheikhHassan MajidAshok RoyRani Pathania

Published in: BJPsych open (2021)

COVID-19-related lockdown resulted in an increase in medication interventions, total consultations and involvement of multidisciplinary teams to manage mental health and behavioural issues in people with intellectual disability and/or autism spectrum disorder.

Keyphrases

intellectual disability
autism spectrum disorder
coronavirus disease
sars cov
mental health
attention deficit hyperactivity disorder
primary care
adverse drug
emergency department
mental illness
working memory